The Board of Pharmacy issued the following information concerning a change to the federal PREP Act authorizing pharmacists “to order and administer,” and qualified pharmacy technicians and interns “to administer” select COVID-19 therapeutics to patient populations authorized by the FDA including monoclonal antibody combinations.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.